Status: Recruiting
Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry
REPTT is an observational, prospective, multi-country, multicentre and non-interventional registry in which at least 300 patients with Thrombotic thrombocytopenic purpura (TTP) in Spain and Portugal will be evaluated. The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.
Participants needed: 300
Trial details
Age: Up to 99Biological sex: AllType: ObservationalSponsor: Fundación Española de Hematología y HemoterapíaUpdated: May 29, 2024Locations: 7Duration: 3 Years
Eligibility criteria
Patients with diagnosis of TTP according to International Consensus criteria fro... [+2]
Inability to comply with study procedures and follow-up exams. [+3]